Location: Bod
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Bod
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre Phase N/A · Nantes University Hospital · NCT05856565 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Eli Lilly and Company · NCT07218380 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis Phase 3 · Fondation Hôpital Saint-Joseph · NCT05674994 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Pfizer · NCT07028853 Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer Phase 2 · Institut Curie · NCT07193394 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) Phase 2/Phase 3 · Merck Sharp & Dohme LLC · NCT07266831 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Phase 1 · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma Phase N/A · University Hospital, Bordeaux · NCT06430424 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease Phase 2 · Boehringer Ingelheim · NCT07355296 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis Phase 1/Phase 2 · Novartis Pharmaceuticals · NCT06704269 French Colorectal ESD Cohort in Experts Centers Phase N/A · University Hospital, Limoges · NCT04592003 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo Phase 2 · Takeda · NCT07108283 A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease Phase 2 · AstraZeneca · NCT07571746 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units NA · Poitiers University Hospital · NCT05686850 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies Phase 1/Phase 2 · CellCentric Ltd. · NCT04068597 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes NA · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections Phase 3 · Centre Hospitalier Universitaire de Nice · NCT05902221 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France) Phase N/A · NovoCure Ltd. · NCT06924099 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena Phase 3 · Merck Sharp & Dohme LLC · NCT07216703 Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors Phase 1/Phase 2 · Centre Leon Berard · NCT07243470 Transplantation After Complete Response In Patients With T-cell Lymphoma NA · Hospices Civils de Lyon · NCT05444712 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma Phase 3 · The Lymphoma Academic Research Organisation · NCT06006117 Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children Phase N/A · University Hospital, Tours · NCT03772119 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati Phase 2 · Novartis Pharmaceuticals · NCT06581198 In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy. Phase 3 · University Hospital, Bordeaux · NCT03998852 Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination NA · University Hospital, Toulouse · NCT06804538
Look up another city
Look up another condition